Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03988114 |
Title | A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer (proMONARCH) |
Acronym | proMONARCH |
Recruitment | Withdrawn |
Gender | both |
Phase | FDA approved |
Variant Requirements | No |
Sponsors | Eli Lilly and Company |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | ITA | DEU | BRA | BEL | AUT | ARG |